February 10, 2011

COLUMBUS, Ohio -- Peter Mohler, a prominent medical researcher, has been named director of the Davis Heart and Lung Research Institute at The Ohio State University. The appointment was approved today (2/11) by the OSU Board of Trustees. 

Mohler comes to Ohio State from the University of Iowa Carver College of Medicine where he is distinguished associate professor of cardiovascular medicine and associate professor of internal medicine and molecular physiology & biophysics.

Mohler will be an asset to Ohio State’s medical research program, according to Dr. Thomas Ryan, director of Ohio State's Heart and Vascular Center.

“Peter is an emerging leader with strong skills as a researcher and team builder,” said Ryan. “He will be an inspiration to young scientists who come to Ohio State, and his own laboratory experience is stellar, earning him a place among the top cardiovascular scientists in the country.”

Prior to joining the University of Iowa faculty in 2006, Mohler was an assistant professor in pathology at Vanderbilt University. He was named a Pew Scholar by the Pew Charitable Trusts in 2007, and a Kavli Scholar of the U.S. National Academy of Sciences in 2009. His research program focuses on solving the pathways underlying potentially fatal human diseases including cardiac arrhythmia, diabetes, and neurological dysfunction. 

He earned a doctorate in molecular physiology in 2000 at the University of North Carolina at Chapel Hill and completed a post-doctoral fellowship in 2004 at the Howard Hughes Medical Institute at Duke University.

Mohler is the recipient of numerous honors and awards for his work and he has been an invited speaker at research conferences around the world. He also is the principal investigator for numerous research grants.

Located on the Medical Center campus, the seven-story Dorothy M. Davis Heart and Lung Research Center provides research space for more than 50 investigators who are conducting basic and clinical research on the prevention, detection and treatment of cardiovascular and pulmonary diseases.


David Crawford
Public Affairs and Media Relations

Share This Story